Citigroup’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-14
| Closed | – | – | 5093 |
|
|
2017
Q1 | $0 | Sell |
14
-4,780
| -100% | – | ﹤0.01% | 4994 |
|
|
2016
Q4 | $25K | Buy |
4,794
+3,555
| +287% | +$18.5K | ﹤0.01% | 4330 |
|
|
2016
Q3 | $31K | Buy |
1,239
+132
| +12% | +$3.3K | ﹤0.01% | 3975 |
|
|
2016
Q2 | $27K | Sell |
1,107
-3,608
| -77% | -$88K | ﹤0.01% | 4047 |
|
|
2016
Q1 | $136K | Buy |
4,715
+3,450
| +273% | +$99.5K | ﹤0.01% | 3773 |
|
|
2015
Q4 | $47K | Buy |
1,265
+1,145
| +954% | +$42.5K | ﹤0.01% | 4123 |
|
|
2015
Q3 | $6K | Buy |
120
+36
| +43% | +$1.8K | ﹤0.01% | 4594 |
|
|
2015
Q2 | $6K | Buy |
+84
| New | +$6K | ﹤0.01% | 4799 |
|
|
2015
Q1 | – | Sell |
-185
| Closed | -$2K | – | 5797 |
|
|
2014
Q4 | $2K | Sell |
185
-2,003
| -92% | -$21.7K | ﹤0.01% | 5258 |
|
|
2014
Q3 | $34K | Sell |
2,188
-31
| -1% | -$482 | ﹤0.01% | 3936 |
|
|
2014
Q2 | $60K | Buy |
2,219
+31
| +1% | +$838 | ﹤0.01% | 3434 |
|
|
2014
Q1 | $59K | Hold |
2,188
| – | – | ﹤0.01% | 3876 |
|
|
2013
Q4 | $54K | Hold |
2,188
| – | – | ﹤0.01% | 4118 |
|
|
2013
Q3 | $70K | Sell |
2,188
-2,375
| -52% | -$76K | ﹤0.01% | 3412 |
|
|
2013
Q2 | $135K | Buy |
+4,563
| New | +$135K | ﹤0.01% | 3042 |
|